Activity Provided By:

Catalyst Medical Education, LLC and AKH Inc., Advancing Knowledge in Healthcare.

Relieving the Treatment Burden: Insights Into the Future of Anti-angiogenic Therapies for Neovascular AMD

Overview / Abstract:	Target Audience This activity is intended for retina specialists and comprehensive ophthalmologists who treat diseases of the retina. Program Overview This symposium recording will review current challenges associated with frequent anti-vascular endothelial growth factor (VEGF) therapy, including the impact on patients, caregivers, and treating physicians. The impact of undertreatment on visual acuity will be discussed. Finally, new anti-VEGF and other anti-angiogenic compounds that are in development, including their pharmacologic properties, mode of action, latest safety and efficacy data, and promise of greater durability will be explored. Learning Objectives Upon completion of this activity, participants should be able to: Compare the safety and efficacy of the different anti-VEGF treatment regimens both in clinical trial and real-world settings Explain the multiple facets of treatment burden for neovascular age-related macular degeneration (AMD) Consider the medical needs and treatment burden for specific patients to individualize therapeutic strategies Review the pharmacologic properties and modes of action of anti-angiogenic compounds in late clinical development Review safety and efficacy data from clinical trials for anti-angiogenic therapies in development with special emphasis on phase 3 clinical programs
Expiration	Apr 03, 2021
Discipline(s)	Physician CME
Format	Online
Credits / Hours	1
Accreditation	ACME
Presenters / Authors / Faculty	Faculty Diana V. Do, MD, FAAO (Co-Chair) Vice Chair of Clinical Affairs Professor of Ophthalmology Byers Eye Institute Stanford University School of Medicine Palo Alto, CA Judy E. Kim, MD Professor of Ophthalmology Vitreoretinal Diseases and Surgery Director, Teleophthalmology and Research Medical College of Wisconsin Milwaukee, WI Quan Dong Nguyen, MD, MSc, FAAO (Co-Chair) Professor of Ophthalmology Byers Eye Institute Stanford University School of Medicine Palo Alto, CA Nathan C. Steinle, MD California Retina Consultants Santa Barbara, CA
Sponsors / Supporters / Grant Providers	Allergan, Inc.
Keywords / Search Terms	Relias LLC FREE CME , Anti-angiogenic Therapies, Relias LLC. Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map